147 related articles for article (PubMed ID: 7831670)
21. An investigation into the effects of nifedipine and nimodipine on platelet function and vascular prostacyclin synthesis.
Jeremy JY; Barradas MA; Mikhailidis DP; Dandona P
Drugs Exp Clin Res; 1985; 11(9):645-51. PubMed ID: 3939725
[TBL] [Abstract][Full Text] [Related]
22. Antiplatelet activity of carnosol is mediated by the inhibition of TXA2 receptor and cytosolic calcium mobilization.
Lee JJ; Jin YR; Lim Y; Hong JT; Kim TJ; Chung JH; Yun YP
Vascul Pharmacol; 2006 Sep; 45(3):148-53. PubMed ID: 16916624
[TBL] [Abstract][Full Text] [Related]
23. Nitric oxide derived from endothelial cells inhibits Na+/H+ exchange in rabbit platelets activated by thrombin.
Chen H; Guo ZG
Zhongguo Yao Li Xue Bao; 1999 Apr; 20(4):333-7. PubMed ID: 10452119
[TBL] [Abstract][Full Text] [Related]
24. Inhibition of platelet aggregation by polyaspartoyl L-arginine and its mechanism.
Wang YY; Tang ZY; Dong M; Liu XY; Peng SQ
Acta Pharmacol Sin; 2004 Apr; 25(4):469-73. PubMed ID: 15066215
[TBL] [Abstract][Full Text] [Related]
25. Matrix metalloproteinase 2 in tumor cell-induced platelet aggregation: regulation by nitric oxide.
Jurasz P; Sawicki G; Duszyk M; Sawicka J; Miranda C; Mayers I; Radomski MW
Cancer Res; 2001 Jan; 61(1):376-82. PubMed ID: 11196190
[TBL] [Abstract][Full Text] [Related]
26. The mechanism of anti-platelet activity of davallialactone: involvement of intracellular calcium ions, extracellular signal-regulated kinase 2 and p38 mitogen-activated protein kinase.
Kim SD; Lee IK; Lee WM; Cho JY; Park HJ; Oh JW; Park SC; Kim SK; Kwak YS; Yun BS; Rhee MH
Eur J Pharmacol; 2008 Apr; 584(2-3):361-7. PubMed ID: 18313047
[TBL] [Abstract][Full Text] [Related]
27. Inhibition of ADP-induced human platelet aggregation by a new class of soluble guanylate cyclase activators capable of nitric oxide generation.
Severina IS; Belushkina NN; Grigoryev NB
Biochem Mol Biol Int; 1994 Aug; 33(5):957-67. PubMed ID: 7987264
[TBL] [Abstract][Full Text] [Related]
28. Effects of bortezomib on platelet aggregation and ATP release in human platelets, in vitro.
Avcu F; Ural AU; Cetin T; Nevruz O
Thromb Res; 2008; 121(4):567-71. PubMed ID: 17910980
[TBL] [Abstract][Full Text] [Related]
29. Peroxynitrite can affect platelet responses by inhibiting energy production.
Rusak T; Tomasiak M; Ciborowski M
Acta Biochim Pol; 2006; 53(4):769-76. PubMed ID: 17068635
[TBL] [Abstract][Full Text] [Related]
30. Effects of magnesium lithospermate B on aggregation and 5-HT release in rabbit washed platelets.
Wang W; Wang YP; Sun WK; Xu YM; Xuan LJ
Acta Pharmacol Sin; 2000 Sep; 21(9):859-63. PubMed ID: 11501172
[TBL] [Abstract][Full Text] [Related]
31. Inhibition of human platelet aggregation by nitric oxide donor drugs: relative contribution of cGMP-independent mechanisms.
Sogo N; Magid KS; Shaw CA; Webb DJ; Megson IL
Biochem Biophys Res Commun; 2000 Dec; 279(2):412-9. PubMed ID: 11118301
[TBL] [Abstract][Full Text] [Related]
32. [Effects of the combination of aspirin and nifedipine on platelet aggregation and thrombogenesis].
Dong E; Shi S
Zhonghua Xin Xue Guan Bing Za Zhi; 1990 Oct; 18(5):301-3, 319. PubMed ID: 2086198
[TBL] [Abstract][Full Text] [Related]
33. Effects of calcium channel blockers on in vitro platelet function in whole blood using single platelet counting.
Walley TJ; Woods KL; Barnett DB
Thromb Haemost; 1989 Feb; 61(1):137-9. PubMed ID: 2749586
[TBL] [Abstract][Full Text] [Related]
34. [Effect of calcium-channel blockers on human thrombocyte aggregation induced by alpha-adrenoreceptor agonists].
Ivleva AIa; Kobalava ZhD; Moiseev VS
Farmakol Toksikol; 1989; 52(2):77-80. PubMed ID: 2568273
[TBL] [Abstract][Full Text] [Related]
35. Effects of the calcium antagonist nifedipine on thromboxane B2 level and platelet aggregation in hypertensive patients.
Uehara S; Handa H; Hirayama A
Arzneimittelforschung; 1986 Nov; 36(11):1687-9. PubMed ID: 3814228
[TBL] [Abstract][Full Text] [Related]
36. Investigation of the existence and biological role of L-arginine/nitric oxide pathway in human platelets by spin-trapping/EPR studies.
Prónai L; Ichimori K; Nozaki H; Nakazawa H; Okino H; Carmichael AJ; Arroyo CM
Eur J Biochem; 1991 Dec; 202(3):923-30. PubMed ID: 1662618
[TBL] [Abstract][Full Text] [Related]
37. Involvement of nitric oxide in the antiaggregatory effect of enalapril.
Shankar RP; Bhargava VK; Grover A; Majumdar S; Garg SK
Methods Find Exp Clin Pharmacol; 2001 Jun; 23(5):255-7. PubMed ID: 11712645
[TBL] [Abstract][Full Text] [Related]
38. Effect of dipyridamole and aspirin on the platelet-neutrophil interaction via the nitric oxide pathway.
De La Cruz JP; Blanco E; Sánchez de la Cuesta F
Eur J Pharmacol; 2000 May; 397(1):35-41. PubMed ID: 10844096
[TBL] [Abstract][Full Text] [Related]
39. Effects of porcine calcitonin on human platelet fuction.
Pogliani EM; Corghi E; Ortolani S; Girardello R; Vigo PL; Polli IE
Biomed Pharmacother; 1984; 38(2):97-101. PubMed ID: 6743778
[TBL] [Abstract][Full Text] [Related]
40. Antiaggregatory activity of N-methyl- and N-isobutyl-1,2-diphenyl ethanolamines in rat platelets.
el Tahir KE; el-Naser MA; Ageel AM; el-Obeid HA; al-Rashood KA
Arch Int Pharmacodyn Ther; 1990; 307():162-71. PubMed ID: 2095711
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
